<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01451684</url>
  </required_header>
  <id_info>
    <org_study_id>TD003</org_study_id>
    <nct_id>NCT01451684</nct_id>
  </id_info>
  <brief_title>Development of a Non-invasive Prenatal Test</brief_title>
  <official_title>Development of a Non-invasive Prenatal Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roche Sequencing Solutions</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Roche Sequencing Solutions</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study to aid in the development of a non-invasive prenatal test that
      may be used to aid in detection of fetal aneuploidy. Pregnant women will be recruited and
      asked to provide a blood sample to be used for general test development purposes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Absence of chromosomal abnormality</measure>
    <time_frame>At time of enrollment</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Pregnancy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study will include women who have a singleton pregnancy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has singleton pregnancy confirmed via evaluation by a healthcare provider

          -  Subject is able to provide informed consent

          -  Subject is â‰¥ 18 years of age

        Exclusion Criteria:

          -  Subject is pregnant with more than one fetus

          -  Subject is unwilling to undergo a blood draw
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Musci, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ariosa Diagnostics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Romielle Aquino</last_name>
    <phone>408-209-9098</phone>
    <email>raquino@ariosadx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Musci, MD</last_name>
    <phone>408-229-7500</phone>
    <email>tmusci@ariosadx.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ariosa Diagnostics</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romielle Aquino</last_name>
      <phone>408-209-9098</phone>
      <email>raquino@ariosadx.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Musci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2011</study_first_submitted>
  <study_first_submitted_qc>October 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2011</study_first_posted>
  <last_update_submitted>July 14, 2016</last_update_submitted>
  <last_update_submitted_qc>July 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>fetus</keyword>
  <keyword>euploid</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

